Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 7, 2014, Pages 1417-1428

  Aung, Lynn Htet Htet ^a   Yin, Rui Xing ^a   Wu, Dong Feng ^a   Wang, Wei ^a   Liu, Cheng Wu ^a   Pan, Shang Ling ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

BUD13 homolog (BUD13); Genetic polymorphisms; Hyperlipidaemia; ZNF259 zinc finger protein 259 (ZNF259)

Indexed keywords

CARRIER PROTEIN; TRIACYLGLYCEROL; ZNF259 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; HYPERLIPIDEMIAS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERLIPIDEMIAS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84904906745     PISSN: 15821838     EISSN: 15824934     Source Type: Journal    
DOI: 10.1111/jcmm.12291     Document Type: Article

References (34)

1. WHO publishes definitive atlas on global heart disease and stroke epidemic. Indian J Med Sci. 2004; 58: 405-6.
2. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000; 355: 675-87.
3. Shekelle RB, Shryock AM, Paul O, et al. Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med. 1981; 304: 65-70.
4. Steinmetz J, Boerwinkle E, Gueguen R, et al. Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis. 1992; 92: 219-27.
5. Perusse L, Rice T, Despres JP, et al. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Arterioscler Thromb Vasc Biol. 1997; 17: 3263-9.
6. Beekman M, Heijmans BT, Martin NG, et al. Heritabilities of apolipoprotein and lipid levels in three countries. Twin Res. 2002; 5: 87-97.
7. Chasman DI, Pare G, Zee RY, et al. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet. 2008; 1: 21-30.
8. Aulchenko YS, Ripatti S, Lindqvist I, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2009; 41: 47-55.
9. Chasman DI, Pare G, Mora S, et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet. 2009; 5: e1000730.
10. Zabaneh D, Chambers JC, Elliott P, et al. Heritability and genetic correlations of insulin resistance and component phenotypes in Asian Indian families using a multivariate analysis. Diabetologia. 2009; 52: 2585-9.
11. Kruglyak L. Genetic isolates: separate but equal? Proc Natl Acad Sci USA. 1999; 96: 1170-2.
12. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010; 466: 707-13.
13. Waterworth DM, Ricketts SL, Song K, et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2010; 30: 2264-76.
14. Nakayama K, Yanagisawa Y, Ogawa A, et al. High prevalence of an anti-hypertriglyceridemic variant of the MLXIPL gene in Central Asia. J Hum Genet. 2011; 56: 828-33. Doi:10.1038/jhg.2011.109.
15. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009; 41: 56-65.
16. Brooks MA, Dziembowski A, Quevillon-Cheruel S, et al. Structure of the yeast Pml1 splicing factor and its integration into the RES complex. Nucleic Acids Res. 2009; 37: 129-43.
17. Galcheva-Gargova Z, Gangwani L, Konstantinov KN, et al. The cytoplasmic zinc finger protein ZPR1 accumulates in the nucleolus of proliferating cells. Mol Biol Cell. 1998; 9: 2963-71.
18. Galcheva-Gargova Z, Konstantinov KN, Wu IH, et al. Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor. Science. 1996; 272: 1797-802.
19. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995; 83: 835-9.
20. Corton JC, Anderson SP, Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol. 2000; 40: 491-518.
21. Sladek FM, Zhong WM, Lai E, et al. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 1990; 4: 2353-65.
22. Ruixing Y, Yuming C, Shangling P, et al. Effects of demographic, dietary and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. Eur J Cardiovasc Prev Rehabil. 2006; 13: 977-84.
23. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. People's Republic of China-United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. Circulation. 1992; 85: 1083-96.
24. Aung LH, Yin RX, Wu DF, et al. Association of the TRIB1 tribbles homolog 1 gene rs17321515 A>G polymorphism and serum lipid levels in the Mulao and Han populations. Lipids Health Dis. 2011; 10: 230. Doi:10.1186/476-511X-10-230.
25. Aung LH, Yin RX, Wu DF, et al. Association of the apolipoprotein M gene polymorphisms and serum lipid levels. Mol Biol Rep. 2013; 40: 1843-53. Doi:10.007/s11033-012-2240-5.
26. Johansen CT, Wang J, Lanktree MB, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet. 2010; 42: 684-7.
27. Grallert H, Dupuis J, Bis JC, et al. Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. Eur Heart J. 2012; 33: 238-51. Doi:10.1093/eurheartj/ehr372.
28. Xu L, Zhou J, Huang S, et al. An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease. Exp Ther Med. 2013; 5: 742-50.
29. Schunkert H, Konig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011; 43: 333-8.
30. Braun TR, Been LF, Singhal A, et al. A replication study of GWAS-derived lipid genes in Asian Indians: the chromosomal region 11q23.3 harbors loci contributing to triglycerides. PLoS ONE. 2012; 7: e37056. Doi:10.1371/journal.pone.0037056.
31. Teo YY, Sim X. Patterns of linkage disequilibrium in different populations: implications and opportunities for lipid-associated loci identified from genome-wide association studies. Curr Opin Lipidol. 2010; 21: 104-15. Doi:10.1097/MOL.0b013e3283369e5b.
32. Merched AJ, Chan L. Nutrigenetics and nutrigenomics of atherosclerosis. Curr Atheroscler Rep. 2013; 15: 328.
33. Kraja AT, Vaidya D, Pankow JS, et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes. 2011; 60: 1329-39.
34. Johansen CT, Kathiresan S, Hegele RA. Genetic determinants of plasma triglycerides. J Lipid Res. 2011; 52: 189-206. Doi:10.1194/jlr.R009720.